Target intelligence / Profile preview

Helminth mitochondrial respiratory chain

Molecular classification
Enzyme, Other
01

Overview

The helminth mitochondrial respiratory chain is a specialized metabolic system essential for the survival of parasitic flatworms, including tapeworms (cestodes). Unlike their mammalian hosts, many adult helminths inhabit anaerobic or microaerobic environments within the host's gastrointestinal tract and rely on a unique anaerobic respiratory pathway known as the NADH-fumarate reductase system (Kita et al., 2012). This system utilizes rhodoquinone as an electron carrier to reduce fumarate to succinate, a process catalyzed by a parasite-specific complex II (fumarate reductase) that differs significantly from the succinate dehydrogenase found in humans (Omura et al., 2001). Drugs such as niclosamide target this machinery by acting as uncouplers of oxidative phosphorylation, which dissipates the mitochondrial proton gradient and halts ATP production (Winn et al., 2021). Other anthelmintics, like certain benzimidazoles and specialized inhibitors like nafuredin, directly interfere with the enzymes of this respiratory chain (Kita et al., 2012). Because of these distinct biochemical adaptations, the tapeworm mitochondrial machinery represents a highly effective target for selective chemotherapy against helminthic infections. Disruption of this machinery leads to rapid ATP depletion, loss of motor function, and eventual death of the parasite.

Other names
Tapeworm mitochondrial functional machineryNADH-fumarate reductase systemCestode mitochondrial respiratory chainHelminth anaerobic respiratory chainFumarate reductase system
02

Mechanism of action

Uncoupling of oxidative phosphorylation and inhibition of the NADH-fumarate reductase system, leading to the dissipation of the mitochondrial membrane potential and depletion of cellular ATP (Kita et al., 2012; Winn et al., 2021).

03

Biological functions

Anaerobic respirationATP synthesisOxidative phosphorylationRedox homeostasis
04

Disease associations

Infection
05

Safety considerations

Potential for host mitochondrial toxicity if systemically absorbedDevelopment of drug resistance in parasite populationsLimited efficacy against certain life stages or tissue-dwelling parasites due to drug distribution challenges
06

Interacting drugs

Niclosamide

7 more in the full profile.

Beyond the preview

Go deeper on Helminth mitochondrial respiratory chain.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Helminth mitochondrial respiratory chain.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call